The decision to scale back recommendations has raised concerns about insurance coverage and future access to COVID vaccines.

Let’s get into this week’s dose of New York public health news, what you can do, and why it matters — from Salmonella being ...

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...

Prior to his confirmation as HHS secretary, the vaccine skeptic insisted he didn't want to take vaccines away.

Kennedy Jr. -- are restricting access to COVID shots that were a signature accomplishment of President Trump's first term and ...

The new Covid-19 subvariant NB.1.8.1, detected in the US after a surge in China, is being closely monitored due to its rapid ...

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1 ...

A new policy announced by the Trump administration may limit which Americans can get a COVID booster when respiratory virus season rolls around this fall and winter.

Italy’s abstention from the WHO Pandemic Agreement raises concerns over national sovereignty and risks isolating the country ...